title: Hypertension due to antiangiogenic cancer therapy with VEGF inhibitors: is autonomic nervous system toxicity another possible mechanism?
authors.forename: William F
authors.initials: WF
authors.lastname: McIntyre
authors.forename: Zardasht
authors.initials: Z
authors.lastname: Oqab
authors.forename: Wilma M
authors.initials: WM
authors.lastname: Hopman
authors.forename: Nazik
authors.initials: N
authors.lastname: Hammad
authors.forename: Adrian
authors.initials: A
authors.lastname: Baranchuk
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D019468:Disease Management; D006801:Humans; D006973:Hypertension; D009369:Neoplasms / Q000188:drug therapy*; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*
chemical_list: D000970:Antineoplastic Agents; D042461:Vascular Endothelial Growth Factor A